One trial reported no significant difference in the occurrence of urinary tract infection
among those receiving amoxicillin-clavulanate compared to those receiving no treatment
(OR 0.50, 95% CI 0.17 to 1.46) or in the occurrence of lymphangiitis (OR 6.75, 95% CI 0.81
to 56.27